MCK
Mckesson Corporation
Stock NYSE – Stock Market Prices, News & Analysis
Mckesson Corporation is a global leader in the distribution of pharmaceutical products and the provision of technology solutions for the healthcare sector.
Mckesson Corporation
MCK
Mckesson Corporation is a global leader in the distribution of pharmaceutical products and the provision of technology solutions for the healthcare sector.
Price history of Mckesson Corporation
Price history of Mckesson Corporation
Performance & Momentum
McKesson Posts Strong Q3, Maintains Buy Despite Sector Drop
McKesson Corporation (Mckesson Corporation) reported a solid third quarter in 2026 with revenues of $106.16 billion and net income of $1.19 billion. The company continued shareholder returns through share buybacks and a quarterly dividend of $0.82. Bank of America upheld its buy rating, raising the price target to $970, highlighting the stock's strong performance in recent months. However, the pharmaceutical distribution sector is under pressure, with McKesson shares down about 4%, reflecting broader declines in logistics and pharmaceutical stocks amid AI-related concerns.
Strategic Analysis
Mckesson Corporation • 2026
McKesson holds a key position in the U.S. healthcare value chain through its pharmaceutical distribution business and related services. The company benefits from a defensive model built on high volumes, deeply embedded customer relationships, and an essential presence with pharmaceutical companies, pharmacies, and care facilities.
- A key player in U.S. pharmaceutical distribution, with operations that are difficult for customers to bypass
- A healthcare services-oriented model that benefits from the recurring nature of sector demand
- A very strong long-term stock performance record, reflecting sustained execution and a market perception of quality
- A business exposed to structural margin pressure in distribution, a sector that is often highly competitive
- Dependence on a regulatory and contractual environment that can weigh on long-term visibility
Momentum is clearly positive and reflects a robust underlying trend, with sustained gains across multiple time horizons. The stock continues to be supported by its defensive profile and the perceived quality of its business model, making it more of a core portfolio holding than a cyclical bet. The lack of recent news flow limits clearly identifiable short-term catalysts, but the stock’s performance confirms persistent market confidence.
Similar stocks to Mckesson Corporation
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
